| Authors: |
Bianco N; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy., Valenza C; Division of New Drug and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Milano M; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy., Multinu R; Division of Interventional Radiology, European Institute of Oncology IRCCS, Milan, Italy., Battaiotto E; Division of New Drug and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Cavallone M; Division of New Drug and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Malvezzi G; Division of New Drug and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Trapani D; Division of New Drug and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Della Vigna P; Division of Interventional Radiology, European Institute of Oncology IRCCS, Milan, Italy., Bonomo G; Division of Interventional Radiology, European Institute of Oncology IRCCS, Milan, Italy., Varano GM; Division of Interventional Radiology, European Institute of Oncology IRCCS, Milan, Italy., Maiettini D; Division of Interventional Radiology, European Institute of Oncology IRCCS, Milan, Italy., Pitoni MG; Division of Interventional Radiology, European Institute of Oncology IRCCS, Milan, Italy., Sangalli C; Clinical Trial Office, European Institute of Oncology IRCCS, Milan, Italy., Munzone E; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy., Curigliano G; Division of New Drug and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it., Colleoni MA; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy., Orsi F; Division of Interventional Radiology, European Institute of Oncology IRCCS, Milan, Italy. |
